Abstract
The specific targeting of immunotoxins enables their wide application in cancer therapy. The A-chain of the ricin protein (RTA) is an N-glycosidase that catalyzes the removal of adenine from the 28S rRNA, preventing protein translation and leading to cell death. Ricin is highly toxic but can only exert its toxic effects from within the cytoplasm. In this study, we linked the anti-HER2 single-chain variable fragment 4D5 scFv and the endoplasmic reticulum-targeting peptide KDEL to the C-terminal of the RTA to construct immunotoxin RTA-4D5-KDEL. In vitro experiments showed that the anticancer effect of RTA-4D5-KDEL towards ovarian cancer cells SKOV-3 increased 440-fold and 28-fold relative to RTA and RTA-4D5, respectively. RTA-4D5-KDEL had a strong inhibitory effect on HER2-overexpressing SKOV-3 cells and caused little damage to normal HEK-293 cells and H460 lung cancer cells. Immunofluorescence experiments showed that the immunotoxin RTA-4D5 could specifically bind to SKOV-3 cells, but not to normal cells HEK-293. The immunotoxin RTA-4D5-KDEL could rapidly localize the recombinant protein to the endoplasmic reticulum. These results suggest that the recombinant immunotoxin RTA-4D5-KDEL has a strong inhibitory effect on ovarian cancer cells that overexpress HER2 but little harm to the normal cells.
Similar content being viewed by others
References
Barbieri L, Batteli MG, Stripe F (1993) Ribosome-inactivating proteins from plants. Biochim Biophys Acta 1154:237–282. https://doi.org/10.1016/0304-4157(93)90002-6
Blythman HE, Casellas P, Gros O, Gros P, Jansen FK, Paolucci F, Pau B, Vidal H (1981) Immunotoxins: hybrid molecules of monoclonal antibodies and a toxin subunit specifically kill tumour cells. Nature 290:145–146. https://doi.org/10.1038/290145a0
Dyba M, Tarasova NI, Michejda CJ (2004) Small molecule toxins targeting tumor receptors. Curr Pharm Des 10:2311–2334. https://doi.org/10.2174/1381612043384024
Endo Y, Mitsui K, Motizuki M, Tsurugi K (1987) The mechanism of action of ricin and related toxic lectins on eukaryotic ribosomes. The site and the characteristics of the modification in 28 S ribosomal RNA caused by the toxins. J Biol Chem 262:5908–5912
Fodstad O, Kvalheim G, Godal A, Lotsberg J, Aamdal S, Høst H, Pihl A (1984) Phase I study of the plant protein ricin. Cancer Res 44:862–865
Kreitman RJ (2009) Recombinant immunotoxins containing truncated bacterial toxins for the treatment of hematologic malignancies. BioDrugs 23:1–13. https://doi.org/10.2165/00063030-200923010-00001
Lambert JM, Goldmacher VS, Collinson AR, Nadler LM, Blättler WA (1991) An immunotoxin prepared with blocked ricin: a natural plant toxin adapted for therapeutic use. Cancer Res 51:6236–6242
Lewis MJ, Pelham HR (1990) A human homologue of the yeast HDEL receptor. Nature 348:162–163. https://doi.org/10.1038/348162a0
Lin JY, Tserng KY, Chen CC, Lin LT, Tung TC (1970) Abrin and ricin: new anti-tumor substances. Nature 227:292–293. https://doi.org/10.1038/227292a0
Lv XX, Zhang J, Xu R, Dong YG, Sun AY, Shen YL, Wei DZ (2016) Gigantoxin-4-4D5 scFv is a novel recombinant immunotoxin with specific toxicity against HER2/neu-positive ovarian carcinoma cells. Appl Microbiol Biotechnol 100:6403–6413. https://doi.org/10.1007/s00253-016-7487-7
Munro S, Pelham HR (1986) An Hsp70-like protein in the ER: identity with the 78 kD glucose-regulated protein and immunoglobulin heavy chain binding protein. Cell 46:291–300. https://doi.org/10.1016/0092-8674(86)90746-4
Munro S, Pelham HR (1987) A C-terminal signal prevents secretion of luminal ER proteins. Cell 48:899–907. https://doi.org/10.1016/0092-8674(87)90086-9
Newton DL, Wales R, Richardson PT, Walbridge S, Saxena SK, Ackerman EJ, Roberts LM, Lord JM, Youle RJ (1992) Cell surface and intracellular functions for ricin galactose binding. J Biol Chem 267:11917–11922
Olsnes S (2004) The history of ricin, abrin, and related toxins. Toxicon 44:361–370. https://doi.org/10.1016/j.toxicon.2004.05.003
Olsnes S, Phil A (1973) Different biological properties of the two constituent peptide chains of ricin a toxic protein inhibiting protein synthesis. Biochemistry 12:3121–3126. https://doi.org/10.1021/bi00740a028
Olsnes S, Fernandez-Puentes C, Carrasco L, Vazquez D (1975) Ribosome inactivation by the toxic lectins abrin and ricin. Kinetics of the enzymic activity of the toxin A-chains. Eur J Biochem 60:281–288. https://doi.org/10.1111/j.1432-1033.1975.tb21001.x
Pincus SH, Marcotte TK, Forsyth BM, Fang H (2001) In vivo testing of anti-HIV immunotoxins. Methods Mol Biol 166:277–294
Press MF, Cordon-Cardo C, Slamon DJ (1990) Expression of the HER-2/neu proto-oncogene in normal human adult and fetal tissues. Oncogene 5:953–962
Satakarni M, Curtis R (2011) Production of recombinant peptides as fusions with SUMO. Protein Expr Purif 78:113–119. https://doi.org/10.1016/j.pep.2011.04.015
Schnell R, Staak O, Borchmann P, Schwartz C, Matthey B, Hansen H, Schindler J, Ghetie V, Vitetta ES, Diehl V, Engert A (2002) A phase I study with an anti-CD30 ricin A-chain immunotoxin (Ki-4.dgA) in patients with refractory CD30+ Hodgkin’s and non-Hodgkin’s lymphoma. Clin Cancer Res 8:1779–1786
Sommaruga S, Lombardi A, Salvadè A, Mazzucchelli S, Corsi F, Galeffi P, Tortora P, Prosperi D (2011) Highly efficient production of anti-HER2 scFv antibody variant for targeting breast cancer cells. Appl Microbiol Biotechnol 91:613–621. https://doi.org/10.1007/s00253-011-3306-3
Spooner RA, Lord JM (2012) How ricin and Shiga toxin reach the cytosol of target cells: retrotranslocation from the endoplasmic reticulum. Curr Top Microbiol Immunol 357:19–40. https://doi.org/10.1007/82_2011_154
Spooner RA, Hart PJ, Cook JP, Pietroni P, Rogon C, Höhfeld J, Roberts LM, Lord JM (2008) Cytosolic chaperones influence the fate of a toxin dislocated from the endoplasmic reticulum. Proc Natl Acad Sci U S A 15:17408–17413. https://doi.org/10.1073/pnas.0809013105
Tsai YL, Zhang Y, Tseng CC, Stanciauskas R, Pinaud F, Lee AS (2015) Characterization and mechanism of stress-induced translocation of 78-kilodalton glucose regulated protein (GRP78) to the cell surface. J Biol Chem 290:8049–8064. https://doi.org/10.1074/jbc.M114.618736
Van Deurs B, Sandvig K, Petersen OW, Olsnes S, Simons K, Griffiths G (1988) Estimation of the amount of internalized ricin that reaches the trans-Golgi network. J Cell Biol 106:253–267. https://doi.org/10.1083/jcb.106.2.253
Vitetta ES, Thorpe PE (1991) Immunotoxins containing ricin or its A chain. Semin Cell Biol 2:47–58
Wales R, Chaddock JA, Roberts LM, Lord JM (1992) Addition of an ER retention signal to the ricin A chain increases the cytotoxicity of the holotoxin. Exp Cell Res 203:1–4. https://doi.org/10.1016/0014-4827(92)90032-4
Wales R, Roberts LM, Lord JM (1993) Addition of an endoplasmic reticulum retrieval sequence to ricin A chain significantly increases its cytotoxicity to mammalian cells. J Biol Chem 268:23986–23990
Willuda J, Honegger A, Waibel R, Schubiger PA, Stahel R, Zangemeister-Wittke U, Plückthun A (1999) High thermal stability is essential for tumor targeting of antibody fragments: engineering of a humanized anti-epithelial glycoprotein-2 (epithelial cell adhesion molecule) single-chain Fv fragment. Cancer Res 59:5758–5767
Zhan JB, Chen YD, Wang KY, Zheng S (2004) Expression of ricin A chain and ricin A chain-KDEL in Escherichia coli. Protein Expr Purif 34:197–201. https://doi.org/10.1016/j.pep.2003.11.009
Zhang J, Lv XX, Xu R, Tao XY, Dong YG, Sun AY, Wei DZ (2015) Soluble expression, rapid purification, and characterization of human interleukin-24 (IL-24) using a MBP-SUMO dual fusion system in Escherichia coli. Appl Microbiol Biotechnol 99:6705–6713. https://doi.org/10.1007/s00253-015-6441-4
Zhang J, Sun AY, Xu R, Tao XY, Dong YG, Lv XX, Wei DZ (2016) Cell-penetrating and endoplasmic reticulum-locating TAT-IL-24-KDEL fusion protein induces tumor apoptosis. J Cell Physiol 231:84–93. https://doi.org/10.1002/jcp.25054
Zhou XX, Ji F, Zhao JL, Cheng LF, Xu CF (2010) Anti-cancer activity of anti-p185HER-2 ricin A chain immunotoxin on gastric cancer cells. J Gastroenterol Hepatol 25:1266–1275. https://doi.org/10.1111/j.1440-1746.2010.06287.x
Funding
This work was funded by the National Natural Science Foundation of China (No. 21778018 and No. 21706072) and the National Special Fund for the State Key Laboratory of Bioreactor Engineering (2060204).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
This study does not contain any studies with human participants or animals performed by any of the authors.
Rights and permissions
About this article
Cite this article
Jiao, P., Zhang, J., Dong, Y. et al. Construction and characterization of the recombinant immunotoxin RTA-4D5-KDEL targeting HER2/neu-positive cancer cells and locating the endoplasmic reticulum. Appl Microbiol Biotechnol 102, 9585–9594 (2018). https://doi.org/10.1007/s00253-018-9291-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00253-018-9291-z